← All indications
Heart Arrest
Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.
Subtype terms (2)
More specific conditions that are subtypes of Heart Arrest in the MeSH hierarchy.
- Death, Sudden, Cardiac
35 drugs (29 approved, 6 experimental)
- Out-of-Hospital Cardiac Arrest
25 drugs (23 approved, 2 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (21)
Phase 3 trials (20)
Phase 2 trials (18)
Phase 1 trials (8)
Organizations
Organization Involved with Phase 4 Indications (17)
- Pfizer
- Chiesi
- Duke University
- Korea University
- Negovsky Reanimatology Research Institute
- University of Toronto
- Yonsei University
- Far Eastern Memorial Hospital
- Kanuni Sultan Suleyman Training and Research Hospital
- Medical University of Vienna
- University of Ljubljana
- University of Lyon
- Technion University
- Ministery of Health
- Canadian Institutes of Health Research (CIHR)
- Sungkyunkwan University
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (24)
- NeuroproteXeon, Inc.
- Boehringer Ingelheim
- National Heart, Lung, and Blood Institute (NHLBI)
- United States Army
- Aarhus University
- American Heart Association
- Changi General Hospital
- University of Washington
- Johns Hopkins University
- Singapore General Hospital
- University of Thessaly
- University of Athens
- University of California, Berkeley
- University of California, San Francisco
- University of Vienna
- University of Limoges
- National University of Singapore
- Janssen Pharmaceutica NV
- University of Paris
- CHU Edouard Herriot
- Heart and Stroke Foundation of Canada
- Defence Research and Development Canada
- Johnson and Johnson
- Government of Singapore
Organization Involved with Phase 2 Indications (42)
- GNT Pharma
- Mallinckrodt
- Maastricht University
- University of Pittsburgh
- Medical University of Graz
- Harvard University
- Curtin University
- Flinders University
- Gelderse Vallei Hospital
- Hanyang University
- Monash University
- Oakland University
- Sint Franciscus Gasthuis
- University of Oslo
- University of British Columbia
- University of Copenhagen
- University of Turku
- University of Ulsan
- Vancouver Coastal Health
- University of Amsterdam
- Free University of Amsterdam
- Amphia Hospital Breda, the Netherlands
- University of Maribor
- Catholic University of Korea
- Soonchunhyang University
- Kyungpook University
- University of Alabama, Birmingham
- Medtronic
- Erasmus University Rotterdam
- South-Eastern Norway Regional Health Authority
- +12 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (17)
- Centre Hospitalier le Mans
- University of London
- Fraser Health
- Radboud University
- Rijnstate Hospital
- University of Groningen
- VieCuri Medical Centre
- University of Twente
- St. Antonius Hospital, Nieuwegein
- National Taiwan University
- Medisch Spectrum Twente
- Free University of Brussels
- University of Nice Sophia Antipolis
- University Hospital, Estaing
- Oslo Metropolitan University
- University Clermont Auvergne
- Barts & The London NHS Trust